Yao H, Zhang A, Li D, Wu Y, Wang CZ, Wan JY, Yuan CS
Regional Insights North America GLP-1 Receptor Agonist Market Insights North America dominated the global GLP-1 Receptor Agonist Market in 2025 with approximately 45% of global revenues, anchored entirely by the United States' unique drug pricing environment and the commercial investment that Novo Nordisk and Eli Lilly have made in building GLP-1 prescribing across endocrinology, primary care, cardiology, and bariatric medicine
Collagen is a crucial component of connective tissues, and exploring the peptides impact on collagen synthesis may provide valuable insights into its potential applications
Sublingual lozenge for enhanced absorption
Do I need L-Glutamine or L-Carnitine if I eat a balanced diet